Fayez Sarofim & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $323K | Sell |
|
|||||
|
2024
Q1 | $860K | Hold |
|
|||||
|
2023
Q4 | $865K | Sell |
|
|||||
|
2023
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q2 | $754K | Sell |
|
|||||
|
2023
Q1 | $3.72M | Buy |
|
|||||
|
2022
Q4 | $3.84M | Sell |
|
|||||
|
2022
Q3 | $2.77M | Sell |
|
|||||
|
2022
Q2 | $2.84M | Sell |
|
|||||
|
2022
Q1 | $3.44M | Sell |
|
|||||
|
2021
Q4 | $9.18M | Buy |
|
|||||
|
2021
Q3 | $7.56M | Sell |
|
|||||
|
2021
Q2 | $7.99M | Buy |
|
|||||
|
2021
Q1 | $5.83M | Sell |
|
|||||
|
2020
Q4 | $5.37M | Sell |
|
|||||
|
2020
Q3 | $6.09M | Sell |
|
|||||
|
2020
Q2 | $7.64M | Buy |
|
|||||
|
2020
Q1 | $7.42M | Hold |
|
|||||
|
2019
Q4 | $6.45M | Sell |
|
|||||
|
2019
Q3 | $6.59M | Sell |
|
|||||
|
2019
Q2 | $7.49M | Sell |
|
|||||
|
2019
Q1 | $7.74M | Sell |
|
|||||
|
2018
Q4 | $7.82M | Sell |
|
|||||
|
2018
Q3 | $9.7M | Sell |
|
|||||
|
2018
Q2 | $10.4M | Sell |
|
|||||
|
2018
Q1 | $12.9M | Sell |
|
|||||
|
2017
Q4 | $15.9M | Sell |
|
|||||
|
2017
Q3 | $20.3M | Sell |
|
|||||
|
2017
Q2 | $33.2M | Sell |
|
|||||
|
2017
Q1 | $45.8M | Sell |
|
|||||
|
2016
Q4 | $95.2M | Sell |
|
|||||
|
2016
Q3 | $111M | Sell |
|
|||||
|
2016
Q2 | $121M | Buy |
|
|||||
|
2016
Q1 | $132M | Buy |
|
|||||
|
2015
Q4 | $127M | Sell |
|
|||||
|
2015
Q3 | $126M | Sell |
|
|||||
|
2015
Q2 | $161M | Sell |
|
|||||
|
2015
Q1 | $139M | Sell |
|
|||||
|
2014
Q4 | $136M | Buy |
|
|||||
|
2014
Q3 | $149M | Buy |
|
|||||
|
2014
Q2 | $110M | Buy |
|
|||||
|
2014
Q1 | $78.4M | Buy |
|